Delays to Neoadjuvant Chemotherapy Have Risks in Bladder Cancer
Several factors, including race, insurance, and type of facility, were associated with delays in neoadjuvant chemotherapy treatment for bladder cancer patients.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Dave Levitan Source Type: news
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | Insurance | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy